yes this is a good one., page-4

my brokers recommendation: "OBJ: long shot of the year is likely to come from this 3 cents speculative transdermal (through the skin) drug delivery story. We have watched it go from 2 cents to 4 cents in the past month. @ 10 cents the company will have a market value of $28M. This is the likely price target we have in mind given the early indicators that the technology does work. Longer term the upside will be determined by human clinical trials (companies such as PSD, NAL and ACR have mkt caps $100 M or more). VERY HIGH RISK Speculative story!!!!!!"